Références

ACMD (2000), Reducing drug-related deaths. A Report by The Advisory Council on the Misuse of Drugs, The Stationery Office, London.

ACPO (2003), Cannabis enforcement guidance, ACPO, London.

Ashton, M. (2003), «The American STAR comes to England», Drug and Alcohol Findings 8, pp. 21–6.

ASPECT Consortium (2004), Tobacco or Health in the European Union, Office des publications des Communautés européennes, Luxembourg.

Bandura, A. (1977), Social learning theory, Prentice-Hall, Englewood Cliffs, NJ.

Bargagli, A. M. et al. (2004), Drug-related mortality and its impact on adult mortality in eight European countries, 6ème Conférence Europad, Paris.

Becoña, E. (2002), Bases Scientifics de la Prevención de lass Drogodependencias, Delegación del Gobierno para el Plan Nacional sobre Drogas, Madrid.

Bird, S. et Rotily, M. (2002), «Inside methodologies for counting blood-borne viruses and injector-inmates’ behavioural risks – results from European prisons», Howard Journal 41(2).

Blystad, H., Blad, L., Tulisov, A. et Aavitsland, P. (2005), ‘Hepatitis B in northwest Russia and the Nordic and Baltic countries: recent trends and prevention activities’, Eurosurveillance Weekly 10: 050310.

Botvin, G. J. (2000), «Preventing drug abuse in schools: social and competence enhancement approaches targeting individual-level etiological factors», Addictive Behaviours 25, pp. 887–97.

Bovenkerk, F. et Hogewind, W. I. M. (2002), Hennepteelt in Nederland: het probleem van criminaliteit en haar bestrijding, Willem Pompe Instituut voor Strafrechtswetenschappen, Utrecht.

Brugal, M. T., Domingo-Salvany, A., Puig, R., et al. (2005), «Evaluating the impact of methadone maintenance programmes on mortality due to overdose and Aids in a cohort of heroin users in Espagne», Addiction, in press.

BKA (Bundeskriminalamt) (2004), Polizeiliche Kriminalstatistik 2003 Bundesrepublik Deutschland. BKA, Wiesbaden.

Butler, G. K. L. et Montgomery, A. M. J. (2004), «Impulsivity, risk taking and recreational “ecstasy” (MDMA) use», Drug and Alcohol Dependence 76, pp. 55–62.

Butters, J. E. (2004), «The impact of peers and social disapproval on high-risk cannabis use: gender differences and implications for drug education», Drugs: Education, Prevention and Policy 11, pp. 381–90.

Calafat, A., Fernández, C., Juan, M., et al. (2003), Enjoying the nightlife in Europe: the Role of moderation, IREFREA España, Palma de Mallorca.

Canning, U., Millward, L., Raj, T. et Warm, D. (2004), Drug use prevention among young people: a review of reviews, Health Development Agency, London.

CND (2004), Situation mondiale en ce qui concerne le trafic de drogues: rapport au Secrétariat, Commission des stupéfiants, Conseil économique et social des Nations unies, Vienne.

CND (2005), Situation mondiale en ce qui concerne le trafic de drogues: rapport au Secrétariat, Commission des stupéfiants, Conseil économique et social des Nations unies, Vienne.

Cuijpers, P., et al. (2002), «The effects of drug abuse prevention at school: the healthy school and drugs project», Addiction 97, pp. 67–73.

Cunningham, J. A. (2001), «Impact of normative feedback on problem drinkers: a small-area population study», Journal of Studies on Alcohol 62, pp. 228–33.

De Wit, A. et Bos, J. (2004) «Cost-effectiveness of needle and syringe exchange programmes: a review of the literature», In Hepatitis C and injecting drug use: impact, costs and policy options, EMCDDA Monographs 7, Observatoire européen des drogues et des toxicomanies, Lisbonne, Lisbon, pp. 329–43.

Drug Misuse Research Division (2004), «Trends in treated problem opiates use in the seven health board areas outside the Eastern Regional Health Authority, 1998 to 2002», Occasional Paper No. 13/2004, Drug Misuse Research Division, Dublin.

OEDT (2001), «Co-ordination of the implementation of the EMCDDA standard guidelines on the drug-related deaths in the EU Member States, and the collection and analysis of information on drug-related deaths», projet CT.99.RTX.04, coordonné par le Trimbos Institute, Observatoire européen des drogues et des toxicomanies, Lisbonne.

OEDT (2003), «National prevalence estimates of problem drug use in the European Union, 1995–2000», CT.00.RTX.23, coordonné par le Institut für Therapieforschung, Munich, Observatoire européen des drogues et des toxicomanies, Lisbonne.

OEDT (2004a), Rapport annuel 2004: l'état du phénomène de la drogue dans l'Union européenne et en Norvège, Observatoire européen des drogues et des toxicomanies, Lisbonne.

OEDT (2004b), «Hepatitis C and injecting drug use: impact, costs and policy options», EMCDDA Monographs 7, Observatoire européen des drogues et des toxicomanies, Lisbonne.

OEDT (2004c), Objectif drogues n° 13. Les surdoses: l'une des principales causes de décès évitables chez les jeunes, Observatoire européen des drogues et des toxicomanies, Lisbonne.

Eurobaromètre (2004), Les jeunes et la drogue, Flash Eurobaromètre 158, Taylor Nelson Sofres, Direction générale «Presse et Communication», Commission européenne, Bruxelles.

EuroHIV (Centre européen pour la surveillance épidémiologique du Sida) (2004), Surveillance du VIH/SIDA en Europe, Rapport annuel 2003, n° 70, Institut de Veille Sanitaire, Saint-Maurice.

Eurostat (2002), Statistiques de la santé: Chiffres clés sur la santé 2002, Office des publications officielles des Communautés européennes, Luxembourg, p. 58.

Eysenbach, G., Powell, J., Englesakis, M., et al. (2004), «Health related virtual communities and electronic support groups: systematic review of the effects of online peer to peer interactions», BMJ 328, p. 1166.

FSW (Fonds Soziales Wien) (2004), Jahresbericht 2003, Fonds Soziales Wien, Vienne.

Ghuran, A. et Nolan, J. (2000), «Recreational drug misuse: issues for the cardiologist», Heart 83, pp. 627–33.

Gowing, L., Farrell, M., Bornemann, R. et Ali, R. (2005), «Substitution treatment of injecting opioid users for prevention of HIV infection» (review), The Cochrane Library, 2005, Issue 2 (www.thecochranelibrary.com).

GLADA (Greater London Alcohol and Drug Allliance) (2004), An evidence base for London crack cocaine strategy, Greater London Alcohol and Drug Alliance, London.

Haasen, C. (2003), Discours lors de la «Conference on treatment monitoring in the EU and the EU action plan on drugs 2000–2004» à l'OEDT, novembre 2003.

Hawks, D., Scott, K., McBride, N., et al. (2002), Prevention of psychoactive substance use: a selected review of what works in the area of prevention, Organisation mondiale de la santé, Genève.

Hibell, B., Andersson, B., Bjarnasson, T., et al. (2004), The ESPAD report 2003: alcohol and other drug use among students in 35 European Countries, Conseil suédois pour l'information sur l'alcool et les autres drogues (CAN) et le Groupe Pompidou du Conseil de l'Europe.

Hwang, S. (2001), «Mental illness and mortality among homeless people», Acta Psychiatrica Scandinavica 103, pp. 81–2.

OICS (2005), Rapport de l'Organe international de contrôle des stupéfiants pour 2004, Organe international de contrôle des stupéfiants des Nations unies, New York.

Korkeila, J. (2000), Measuring aspects of mental health, Themes 6/2000, STAKES: Helsinki.

Kumpfer, K. L., Alvarado, R. et Whiteside, H. O. (2003), «Family-based interventions for substance use and misuse prevention», Substance Use and Misuse 38, pp. 1759–87.

Leppin, A. (2004), Vortrag zur schulischen Suchtprävention im Rahmen der Fachtagung ’Qualität schulischer Suchtprävention’ am 20.04.04 in Kärnten.

Macchia, T., Giannotti, F. C. et Taggi, F. (2004), I servizi e le sostanze ricreazionali: una rilevazione clinica in Italia, FrancoAngeli, Milan.

Matheï, C., Robaeys, G., van Damme, P., et al. (2005), «Prevalence of hepatitis C in drug users in Flanders: determinants and geographic differences», Epidemiology and Infection 133, pp. 127–36.

Mendes, F., Relvas, A. P., Olaio, A., et al. (2001), The challenge of prevention of drug use, IREFREA España, Palma de Mallorca.

Mol, A., Van Vlaanderen, J. L. et De Vos, A. (2002), Ontwikkeling van de cocaïne hulpvraag in the ambulante verslavingszorg 1994–2000, IVZ, Houten.

Morral, A. R., McCaffrey, D. F. et Paddock, S. M. (2002), «Reassessing the marijuana gateway effect», Addiction 97, pp. 1493–504.

National Treatment Agency (NTA) (2003), «New guidance on injectable heroin and injectable methadone treatment for opiate misusers», communiqué de presse du 13 juin 2003.

National Treatment Agency (NTA) (2004), «54 per cent more drug misusers get treatment in England», communiqué de presse du 30 septembre 2004.

Ouwehand, A., Van Alem, V., Mol, A. et Boonzajer Flaes, S. (2004), Key figures addiction care 2003, IVZ, Houten (http://www.sivz.nl).

Pijlman, F. T. A., Krul, J. et Niesink, R. J. M. (2003), Uitgaan en Veiligheid: Feiten en Fictie over Alcohol, Drugs en Gezondheidsverstoringen, Trimbos-instituut, Utrecht.

Prinzleve M., Haasen C., Zurhold H., et al. (2004), «Cocaine use in Europe – a multi-centre study: patterns of use in different groups», European Addiction Research 10, pp. 147–55.

Quensel, S. (2004), Das Elend der Suchtprävention, Verlag für Sozialwissenschaften (VS), Wiesbaden.

Reis, J., Riley, W., Lokman, L. et Baer, J. (2000), «Interactive multimedia preventive alcohol education: a technology application in higher education», Journal of Drug Education 30, pp. 399–421.

Rapports nationaux Reitox (2004).

Rhodes, T., Lilly, R., Fernández, C., et al. (2003), «Risk factors associated with drug use: the importance of “risk environment”», Drugs: Education, Prevention and Policy 10, pp. 303–29.

Rigter, H., Van Gageldonk, A., Ketelaars, T. et Van Laar, M. (2004), «Hulp bij probleemgebruik van drugs: stand van wetenschap voor behandelingen en andere interventies, 2004», Trimbos Institute/National Drug Monitor (NDM), Utrecht.

SAMHSA, Office of Applied Studies, 2003 National Survey on Drug Use and Health.

Solberg, U., Burkhart, G. et Nilson, M. (2002), «An overview of opiate substitution treatment in the European Union and Norvège», International Journal of Drug Policy 13, pp. 477–84.

Sullivan, L. E., Metzger, D. S., Fudala, P. J. et Fiellin, D. A. (2005), «Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users»’, Addiction 100, pp. 150–8.

Sussman, S., Earleywine, M., Wills, T., et al. (2004), «The motivation, skills and decision-making model of “drug abuse” prevention», Substance Use and Misuse 39, pp. 1971–2016.

Taylor, B. J. (2000), «‘Modeling prevention program effects on growth in substance use: analysis of five years of data from the Adolescent Alcohol Prevention Trial», Prevention Science 1, pp. 183–97.

Terweij, M. et Van Wamel, A. (2004), Ouders aan zet: opvoedingsondersteuning en verslavingspreventie voor allochtonen: succes- en faalfactoren, GGZ Nederland, Utrecht.

ONUDC (2002), Contemporary drug abuse treatment: a review of the evidence base, Office des Nations unies contre la drogue et le crime, Vienne.

ONUDC (2003a), Tendances mondiales des drogues illicites 2003, Office des Nations unies contre la drogue et le crime, Vienne

ONUDC (2003b), Ecstasy and amphetamines: global Survey 2003, Office des Nations unies contre la drogue et le crime, Vienne.

ONUDC et Gouvernement du Maroc (2003), Maroc: Enquête sur le cannabis 2003, Office des Nations unies contre la drogue et le crime, Vienne.

OMS (1998), Opioid overdose: trends, risk factors, interventions and priorities for action, Organisation mondiale de la santé, Programme sur l'abus de substances psychoactives, Division Santé mentale et Abus de substances psychoactives, Genève.

OMS (2004), «Effectiveness of sterile needle and syringe programming in reducing HIV/AIDS among injecting drug users», Evidence for action technical papers, OMS, Genève.

OMS (2005), «Effectiveness of drug dependence treatment in preventing HIV among injecting drug users», Evidence for action technical papers, final draft, March 2005, OMS, Genève.

OMS, Bureau régional de l'Europe (2002), Prisons, Drugs and Society, A Consensus Statement on Principles, Policies and Practices, Bureau régional de l'Europe, OMS, Genève.